Table of Content

1 IBS-C Drugs Market Overview
1.1 Product Overview and Scope of IBS-C Drugs
1.2 IBS-C Drugs Segment by Type
1.2.1 Global IBS-C Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Linaclotide
1.2.3 Lubiprostone
1.2.4 Osmotic Laxatives
1.2.5 Stimulant Laxatives
1.2.6 Others
1.3 IBS-C Drugs Segment by Application
1.3.1 Global IBS-C Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drugs Market Size Estimates and Forecasts
1.4.1 Global IBS-C Drugs Revenue 2024-2034
1.4.2 Global IBS-C Drugs Sales 2024-2034
1.4.3 Global IBS-C Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 IBS-C Drugs Market Competition by Manufacturers
2.1 Global IBS-C Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global IBS-C Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global IBS-C Drugs Average Price by Manufacturers (2024-2024)
2.4 Global IBS-C Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of IBS-C Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IBS-C Drugs, Product Type & Application
2.7 IBS-C Drugs Market Competitive Situation and Trends
2.7.1 IBS-C Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IBS-C Drugs Players Market Share by Revenue
2.7.3 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IBS-C Drugs Retrospective Market Scenario by Region
3.1 Global IBS-C Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global IBS-C Drugs Global IBS-C Drugs Sales by Region: 2024-2034
3.2.1 Global IBS-C Drugs Sales by Region: 2024-2024
3.2.2 Global IBS-C Drugs Sales by Region: 2024-2034
3.3 Global IBS-C Drugs Global IBS-C Drugs Revenue by Region: 2024-2034
3.3.1 Global IBS-C Drugs Revenue by Region: 2024-2024
3.3.2 Global IBS-C Drugs Revenue by Region: 2024-2034
3.4 North America IBS-C Drugs Market Facts & Figures by Country
3.4.1 North America IBS-C Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America IBS-C Drugs Sales by Country (2024-2034)
3.4.3 North America IBS-C Drugs Revenue by Country (2024-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe IBS-C Drugs Market Facts & Figures by Country
3.5.1 Europe IBS-C Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe IBS-C Drugs Sales by Country (2024-2034)
3.5.3 Europe IBS-C Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IBS-C Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific IBS-C Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific IBS-C Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific IBS-C Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America IBS-C Drugs Market Facts & Figures by Country
3.7.1 Latin America IBS-C Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America IBS-C Drugs Sales by Country (2024-2034)
3.7.3 Latin America IBS-C Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IBS-C Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IBS-C Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa IBS-C Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa IBS-C Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global IBS-C Drugs Sales by Type (2024-2034)
4.1.1 Global IBS-C Drugs Sales by Type (2024-2024)
4.1.2 Global IBS-C Drugs Sales by Type (2024-2034)
4.1.3 Global IBS-C Drugs Sales Market Share by Type (2024-2034)
4.2 Global IBS-C Drugs Revenue by Type (2024-2034)
4.2.1 Global IBS-C Drugs Revenue by Type (2024-2024)
4.2.2 Global IBS-C Drugs Revenue by Type (2024-2034)
4.2.3 Global IBS-C Drugs Revenue Market Share by Type (2024-2034)
4.3 Global IBS-C Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global IBS-C Drugs Sales by Application (2024-2034)
5.1.1 Global IBS-C Drugs Sales by Application (2024-2024)
5.1.2 Global IBS-C Drugs Sales by Application (2024-2034)
5.1.3 Global IBS-C Drugs Sales Market Share by Application (2024-2034)
5.2 Global IBS-C Drugs Revenue by Application (2024-2034)
5.2.1 Global IBS-C Drugs Revenue by Application (2024-2024)
5.2.2 Global IBS-C Drugs Revenue by Application (2024-2034)
5.2.3 Global IBS-C Drugs Revenue Market Share by Application (2024-2034)
5.3 Global IBS-C Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Catalent Pharmaceuticals Solutions
6.1.1 Catalent Pharmaceuticals Solutions Corporation Information
6.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview
6.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolio
6.1.5 Catalent Pharmaceuticals Solutions Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Corporation Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Nestle IBS-C Drugs Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Abbott Laboratories IBS-C Drugs Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Synergy Pharmaceuticals
6.4.1 Synergy Pharmaceuticals Corporation Information
6.4.2 Synergy Pharmaceuticals Description and Business Overview
6.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Synergy Pharmaceuticals IBS-C Drugs Product Portfolio
6.4.5 Synergy Pharmaceuticals Recent Developments/Updates
6.5 Sucampo Pharmaceuticals
6.5.1 Sucampo Pharmaceuticals Corporation Information
6.5.2 Sucampo Pharmaceuticals Description and Business Overview
6.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sucampo Pharmaceuticals IBS-C Drugs Product Portfolio
6.5.5 Sucampo Pharmaceuticals Recent Developments/Updates
6.6 Novartis Pharma Ag
6.6.1 Novartis Pharma Ag Corporation Information
6.6.2 Novartis Pharma Ag Description and Business Overview
6.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Novartis Pharma Ag IBS-C Drugs Product Portfolio
6.6.5 Novartis Pharma Ag Recent Developments/Updates
6.7 Astellas Pharmaceuticals
6.6.1 Astellas Pharmaceuticals Corporation Information
6.6.2 Astellas Pharmaceuticals Description and Business Overview
6.6.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Astellas Pharmaceuticals IBS-C Drugs Product Portfolio
6.7.5 Astellas Pharmaceuticals Recent Developments/Updates
6.8 Ardelyx, Inc
6.8.1 Ardelyx, Inc Corporation Information
6.8.2 Ardelyx, Inc Description and Business Overview
6.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Ardelyx, Inc IBS-C Drugs Product Portfolio
6.8.5 Ardelyx, Inc Recent Developments/Updates
6.9 Synthetic Biologics, Inc
6.9.1 Synthetic Biologics, Inc Corporation Information
6.9.2 Synthetic Biologics, Inc Description and Business Overview
6.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Synthetic Biologics, Inc IBS-C Drugs Product Portfolio
6.9.5 Synthetic Biologics, Inc Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Teva Pharmaceutical Industries IBS-C Drugs Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Bama-Geve, SLU
6.11.1 Bama-Geve, SLU Corporation Information
6.11.2 Bama-Geve, SLU IBS-C Drugs Description and Business Overview
6.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Bama-Geve, SLU IBS-C Drugs Product Portfolio
6.11.5 Bama-Geve, SLU Recent Developments/Updates
6.12 Ferring BV
6.12.1 Ferring BV Corporation Information
6.12.2 Ferring BV IBS-C Drugs Description and Business Overview
6.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Ferring BV IBS-C Drugs Product Portfolio
6.12.5 Ferring BV Recent Developments/Updates
6.13 Ironwood Pharmaceuticals, Inc
6.13.1 Ironwood Pharmaceuticals, Inc Corporation Information
6.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Description and Business Overview
6.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Portfolio
6.13.5 Ironwood Pharmaceuticals, Inc Recent Developments/Updates
6.14 Salix Pharmaceuticals Ltd
6.14.1 Salix Pharmaceuticals Ltd Corporation Information
6.14.2 Salix Pharmaceuticals Ltd IBS-C Drugs Description and Business Overview
6.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolio
6.14.5 Salix Pharmaceuticals Ltd Recent Developments/Updates
6.15 Norgine B.V
6.15.1 Norgine B.V Corporation Information
6.15.2 Norgine B.V IBS-C Drugs Description and Business Overview
6.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Norgine B.V IBS-C Drugs Product Portfolio
6.15.5 Norgine B.V Recent Developments/Updates
6.16 Prometheus Laboratories Inc
6.16.1 Prometheus Laboratories Inc Corporation Information
6.16.2 Prometheus Laboratories Inc IBS-C Drugs Description and Business Overview
6.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Prometheus Laboratories Inc IBS-C Drugs Product Portfolio
6.16.5 Prometheus Laboratories Inc Recent Developments/Updates
6.17 Actavis Nordic A/S
6.17.1 Actavis Nordic A/S Corporation Information
6.17.2 Actavis Nordic A/S IBS-C Drugs Description and Business Overview
6.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Actavis Nordic A/S IBS-C Drugs Product Portfolio
6.17.5 Actavis Nordic A/S Recent Developments/Updates
6.18 Albireo Pharma Inc
6.18.1 Albireo Pharma Inc Corporation Information
6.18.2 Albireo Pharma Inc IBS-C Drugs Description and Business Overview
6.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Albireo Pharma Inc IBS-C Drugs Product Portfolio
6.18.5 Albireo Pharma Inc Recent Developments/Updates
6.19 Yuhan Corp
6.19.1 Yuhan Corp Corporation Information
6.19.2 Yuhan Corp IBS-C Drugs Description and Business Overview
6.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Yuhan Corp IBS-C Drugs Product Portfolio
6.19.5 Yuhan Corp Recent Developments/Updates
6.20 Astrazeneca Plc
6.20.1 Astrazeneca Plc Corporation Information
6.20.2 Astrazeneca Plc IBS-C Drugs Description and Business Overview
6.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Astrazeneca Plc IBS-C Drugs Product Portfolio
6.20.5 Astrazeneca Plc Recent Developments/Updates
6.21 The Menarini Group
6.21.1 The Menarini Group Corporation Information
6.21.2 The Menarini Group IBS-C Drugs Description and Business Overview
6.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.21.4 The Menarini Group IBS-C Drugs Product Portfolio
6.21.5 The Menarini Group Recent Developments/Updates
6.22 Ono Pharmaceutical Co., Ltd
6.22.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.22.2 Ono Pharmaceutical Co., Ltd IBS-C Drugs Description and Business Overview
6.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Portfolio
6.22.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IBS-C Drugs Industry Chain Analysis
7.2 IBS-C Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IBS-C Drugs Production Mode & Process
7.4 IBS-C Drugs Sales and Marketing
7.4.1 IBS-C Drugs Sales Channels
7.4.2 IBS-C Drugs Distributors
7.5 IBS-C Drugs Customers
8 IBS-C Drugs Market Dynamics
8.1 IBS-C Drugs Industry Trends
8.2 IBS-C Drugs Market Drivers
8.3 IBS-C Drugs Market Challenges
8.4 IBS-C Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global IBS-C Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global IBS-C Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global IBS-C Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global IBS-C Drugs Sales (K Pcs) of Key Manufacturers (2024-2024)
Table 5. Global IBS-C Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global IBS-C Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global IBS-C Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market IBS-C Drugs Average Price (USD/Pcs) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of IBS-C Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of IBS-C Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IBS-C Drugs, Product Type & Application
Table 12. Global Key Manufacturers of IBS-C Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IBS-C Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS-C Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IBS-C Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global IBS-C Drugs Sales by Region (2024-2024) & (K Pcs)
Table 18. Global IBS-C Drugs Sales Market Share by Region (2024-2024)
Table 19. Global IBS-C Drugs Sales by Region (2024-2034) & (K Pcs)
Table 20. Global IBS-C Drugs Sales Market Share by Region (2024-2034)
Table 21. Global IBS-C Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global IBS-C Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global IBS-C Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global IBS-C Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America IBS-C Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America IBS-C Drugs Sales by Country (2024-2024) & (K Pcs)
Table 27. North America IBS-C Drugs Sales by Country (2024-2034) & (K Pcs)
Table 28. North America IBS-C Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America IBS-C Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe IBS-C Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe IBS-C Drugs Sales by Country (2024-2024) & (K Pcs)
Table 32. Europe IBS-C Drugs Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe IBS-C Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe IBS-C Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific IBS-C Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific IBS-C Drugs Sales by Region (2024-2024) & (K Pcs)
Table 37. Asia Pacific IBS-C Drugs Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific IBS-C Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific IBS-C Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America IBS-C Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America IBS-C Drugs Sales by Country (2024-2024) & (K Pcs)
Table 42. Latin America IBS-C Drugs Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America IBS-C Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America IBS-C Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa IBS-C Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa IBS-C Drugs Sales by Country (2024-2024) & (K Pcs)
Table 47. Middle East & Africa IBS-C Drugs Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa IBS-C Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa IBS-C Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global IBS-C Drugs Sales (K Pcs) by Type (2024-2024)
Table 51. Global IBS-C Drugs Sales (K Pcs) by Type (2024-2034)
Table 52. Global IBS-C Drugs Sales Market Share by Type (2024-2024)
Table 53. Global IBS-C Drugs Sales Market Share by Type (2024-2034)
Table 54. Global IBS-C Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global IBS-C Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global IBS-C Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global IBS-C Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global IBS-C Drugs Price (USD/Pcs) by Type (2024-2024)
Table 59. Global IBS-C Drugs Price (USD/Pcs) by Type (2024-2034)
Table 60. Global IBS-C Drugs Sales (K Pcs) by Application (2024-2024)
Table 61. Global IBS-C Drugs Sales (K Pcs) by Application (2024-2034)
Table 62. Global IBS-C Drugs Sales Market Share by Application (2024-2024)
Table 63. Global IBS-C Drugs Sales Market Share by Application (2024-2034)
Table 64. Global IBS-C Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global IBS-C Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global IBS-C Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global IBS-C Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global IBS-C Drugs Price (USD/Pcs) by Application (2024-2024)
Table 69. Global IBS-C Drugs Price (USD/Pcs) by Application (2024-2034)
Table 70. Catalent Pharmaceuticals Solutions Corporation Information
Table 71. Catalent Pharmaceuticals Solutions Description and Business Overview
Table 72. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 73. Catalent Pharmaceuticals Solutions IBS-C Drugs Product
Table 74. Catalent Pharmaceuticals Solutions Recent Developments/Updates
Table 75. Nestle Corporation Information
Table 76. Nestle Description and Business Overview
Table 77. Nestle IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 78. Nestle IBS-C Drugs Product
Table 79. Nestle Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 83. Abbott Laboratories IBS-C Drugs Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Synergy Pharmaceuticals Corporation Information
Table 86. Synergy Pharmaceuticals Description and Business Overview
Table 87. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 88. Synergy Pharmaceuticals IBS-C Drugs Product
Table 89. Synergy Pharmaceuticals Recent Developments/Updates
Table 90. Sucampo Pharmaceuticals Corporation Information
Table 91. Sucampo Pharmaceuticals Description and Business Overview
Table 92. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 93. Sucampo Pharmaceuticals IBS-C Drugs Product
Table 94. Sucampo Pharmaceuticals Recent Developments/Updates
Table 95. Novartis Pharma Ag Corporation Information
Table 96. Novartis Pharma Ag Description and Business Overview
Table 97. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 98. Novartis Pharma Ag IBS-C Drugs Product
Table 99. Novartis Pharma Ag Recent Developments/Updates
Table 100. Astellas Pharmaceuticals Corporation Information
Table 101. Astellas Pharmaceuticals Description and Business Overview
Table 102. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 103. Astellas Pharmaceuticals IBS-C Drugs Product
Table 104. Astellas Pharmaceuticals Recent Developments/Updates
Table 105. Ardelyx, Inc Corporation Information
Table 106. Ardelyx, Inc Description and Business Overview
Table 107. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 108. Ardelyx, Inc IBS-C Drugs Product
Table 109. Ardelyx, Inc Recent Developments/Updates
Table 110. Synthetic Biologics, Inc Corporation Information
Table 111. Synthetic Biologics, Inc Description and Business Overview
Table 112. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 113. Synthetic Biologics, Inc IBS-C Drugs Product
Table 114. Synthetic Biologics, Inc Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Corporation Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 118. Teva Pharmaceutical Industries IBS-C Drugs Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Bama-Geve, SLU Corporation Information
Table 121. Bama-Geve, SLU Description and Business Overview
Table 122. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 123. Bama-Geve, SLU IBS-C Drugs Product
Table 124. Bama-Geve, SLU Recent Developments/Updates
Table 125. Ferring BV Corporation Information
Table 126. Ferring BV Description and Business Overview
Table 127. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 128. Ferring BV IBS-C Drugs Product
Table 129. Ferring BV Recent Developments/Updates
Table 130. Ironwood Pharmaceuticals, Inc Corporation Information
Table 131. Ironwood Pharmaceuticals, Inc Description and Business Overview
Table 132. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 133. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product
Table 134. Ironwood Pharmaceuticals, Inc Recent Developments/Updates
Table 135. Salix Pharmaceuticals Ltd Corporation Information
Table 136. Salix Pharmaceuticals Ltd Description and Business Overview
Table 137. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 138. Salix Pharmaceuticals Ltd IBS-C Drugs Product
Table 139. Salix Pharmaceuticals Ltd Recent Developments/Updates
Table 140. Norgine B.V Corporation Information
Table 141. Norgine B.V Description and Business Overview
Table 142. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 143. Norgine B.V IBS-C Drugs Product
Table 144. Norgine B.V Recent Developments/Updates
Table 145. Prometheus Laboratories Inc Corporation Information
Table 146. Prometheus Laboratories Inc Description and Business Overview
Table 147. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 148. Prometheus Laboratories Inc IBS-C Drugs Product
Table 149. Prometheus Laboratories Inc Recent Developments/Updates
Table 150. Actavis Nordic A/S Corporation Information
Table 151. Actavis Nordic A/S Description and Business Overview
Table 152. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 153. Actavis Nordic A/S IBS-C Drugs Product
Table 154. Actavis Nordic A/S Recent Developments/Updates
Table 155. Albireo Pharma Inc Corporation Information
Table 156. Albireo Pharma Inc Description and Business Overview
Table 157. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 158. Albireo Pharma Inc IBS-C Drugs Product
Table 159. Albireo Pharma Inc Recent Developments/Updates
Table 160. Yuhan Corp Corporation Information
Table 161. Yuhan Corp Description and Business Overview
Table 162. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 163. Yuhan Corp IBS-C Drugs Product
Table 164. Yuhan Corp Recent Developments/Updates
Table 165. Astrazeneca Plc Corporation Information
Table 166. Astrazeneca Plc Description and Business Overview
Table 167. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 168. Astrazeneca Plc IBS-C Drugs Product
Table 169. Astrazeneca Plc Recent Developments/Updates
Table 170. The Menarini Group Corporation Information
Table 171. The Menarini Group Description and Business Overview
Table 172. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 173. The Menarini Group IBS-C Drugs Product
Table 174. The Menarini Group Recent Developments/Updates
Table 175. Ono Pharmaceutical Co., Ltd Corporation Information
Table 176. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 177. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2024)
Table 178. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product
Table 179. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. IBS-C Drugs Distributors List
Table 183. IBS-C Drugs Customers List
Table 184. IBS-C Drugs Market Trends
Table 185. IBS-C Drugs Market Drivers
Table 186. IBS-C Drugs Market Challenges
Table 187. IBS-C Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IBS-C Drugs
Figure 2. Global IBS-C Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global IBS-C Drugs Market Share by Type in 2022 & 2034
Figure 4. Linaclotide Product Picture
Figure 5. Lubiprostone Product Picture
Figure 6. Osmotic Laxatives Product Picture
Figure 7. Stimulant Laxatives Product Picture
Figure 8. Others Product Picture
Figure 9. Global IBS-C Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global IBS-C Drugs Market Share by Application in 2022 & 2034
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global IBS-C Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global IBS-C Drugs Market Size (2024-2034) & (US$ Million)
Figure 16. Global IBS-C Drugs Sales (2024-2034) & (K Pcs)
Figure 17. Global IBS-C Drugs Average Price (USD/Pcs) & (2024-2034)
Figure 18. IBS-C Drugs Report Years Considered
Figure 19. IBS-C Drugs Sales Share by Manufacturers in 2022
Figure 20. Global IBS-C Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest IBS-C Drugs Players: Market Share by Revenue in 2022
Figure 22. IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global IBS-C Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America IBS-C Drugs Sales Market Share by Country (2024-2034)
Figure 25. North America IBS-C Drugs Revenue Market Share by Country (2024-2034)
Figure 26. U.S. IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe IBS-C Drugs Sales Market Share by Country (2024-2034)
Figure 29. Europe IBS-C Drugs Revenue Market Share by Country (2024-2034)
Figure 30. Germany IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific IBS-C Drugs Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific IBS-C Drugs Revenue Market Share by Region (2024-2034)
Figure 37. China IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Taiwan IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Indonesia IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Thailand IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Malaysia IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Philippines IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Latin America IBS-C Drugs Sales Market Share by Country (2024-2034)
Figure 48. Latin America IBS-C Drugs Revenue Market Share by Country (2024-2034)
Figure 49. Mexico IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Brazil IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Argentina IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa IBS-C Drugs Sales Market Share by Country (2024-2034)
Figure 53. Middle East & Africa IBS-C Drugs Revenue Market Share by Country (2024-2034)
Figure 54. Turkey IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. U.A.E IBS-C Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 57. Global Sales Market Share of IBS-C Drugs by Type (2024-2034)
Figure 58. Global Revenue Market Share of IBS-C Drugs by Type (2024-2034)
Figure 59. Global IBS-C Drugs Price (USD/Pcs) by Type (2024-2034)
Figure 60. Global Sales Market Share of IBS-C Drugs by Application (2024-2034)
Figure 61. Global Revenue Market Share of IBS-C Drugs by Application (2024-2034)
Figure 62. Global IBS-C Drugs Price (USD/Pcs) by Application (2024-2034)
Figure 63. IBS-C Drugs Value Chain
Figure 64. IBS-C Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed